Comment on: Pharmacokinetics of inhaled colistin in patients with cystic fibrosis

被引：10
|
作者：
Li, Jian [1 ]
Nation, Roger L. [1 ]
机构：
[1] Monash Univ, Victorian Coll Pharm, Facil Anti Infect Drug Dev & Innovat, Melbourne, Vic 3004, Australia
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2006年 / 58卷 / 01期
关键词：
colistin methanesulphonate; pharmacokinetics; inhalation; cystic fibrosis; PERFORMANCE LIQUID-CHROMATOGRAPHY; METHANESULFONATE; PLASMA;
D O I：
10.1093/jac/dkl169
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：222 / 223
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics of meropenem in patients with cystic fibrosis
    Christensson, BA
    Ljungberg, B
    Eriksson, L
    Nilsson-Ehle, I
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (12) : 873 - 876
  • [22] Pharmacokinetics of Meropenem in Patients with Cystic Fibrosis
    B. A. Christensson
    B. Ljungberg
    L. Eriksson
    I. Nilsson-Ehle
    European Journal of Clinical Microbiology and Infectious Diseases, 1998, 17 : 873 - 876
  • [23] PHARMACOKINETICS OF INHALED SALBUTAMOL IN PATIENTS WITH CYSTIC-FIBROSIS VERSUS HEALTHY-YOUNG ADULTS
    VAISMAN, N
    KOREN, G
    GOLDSTEIN, D
    CANNY, GJ
    TAN, YK
    SOLDIN, S
    PENCHARZ, P
    JOURNAL OF PEDIATRICS, 1987, 111 (06): : 914 - 917
  • [24] USE OF INHALED TOBRAMYCIN IN PATIENTS WITH CYSTIC FIBROSIS
    Chermensky, A. G.
    Gembitskaya, M. E.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (08) : 76 - 78
  • [25] Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis
    Blanco-Aparicio, Marina
    Luis Saleta Canosa, Jesus
    Valino Lopez, Paz
    Martin Egana, Maria Teresa
    Vidal Garcia, Iria
    Montero Martinez, Carmen
    CHRONIC RESPIRATORY DISEASE, 2019, 16
  • [26] SAFETY OF INHALED TOBRAMYCIN IN PATIENTS WITH CYSTIC FIBROSIS
    McColley, S.
    Rietschel, E.
    Brockhaus, F.
    Angyalosi, G.
    Higgins, M.
    PEDIATRIC PULMONOLOGY, 2011, : 344 - 344
  • [27] Inhaled Colistin for the Treatment of Tracheobronchitis and Pneumonia in Critically Ill Children Without Cystic Fibrosis
    Falagas, Matthew E.
    Sideri, Georgia
    Korbila, Ioanna P.
    Vouloumanou, Evridiki K.
    Papadatos, John H.
    Kafetzis, Dimitris A.
    PEDIATRIC PULMONOLOGY, 2010, 45 (11) : 1135 - 1140
  • [28] Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis
    Westerman, EM
    Le Brun, PPH
    Touw, DJ
    Frijlink, HW
    Heijerman, HGM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 113 - 113
  • [29] Inhaled Colistin in Elderly Patients With Non-Cystic Fibrosis Bronchiectasis and Chronic Pseudomonas aeruginosa (PA) Bronchial Infection
    Tabernero, Eva
    Gil, Pilar
    Alkiza, Ramon
    Garros, Javier
    Hernandez, Anibal
    Luis Artola, Juan
    CHEST, 2014, 145 (03)
  • [30] Colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis patients
    Claus, Barbara O. M.
    Snauwaert, Sylvia
    Haerynck, Filomeen
    Van Daele, Sabine
    De Baets, Frans
    Schelstraete, Petra
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (04) : 555 - 558
12345